Ling Li
Impact in
-
- Diabetes Treatment and Management
- Thyroid Disorders and Treatments
- Obstetrics and Gynecology top 1%
- Gestational Diabetes Research and Management
Papers in
-
- Gestational Diabetes Research and Management 27
- Pregnancy and preeclampsia studies 10
-
- Diabetes Treatment and Management 19
- Thyroid Disorders and Treatments 13
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Co-authors
- Ping Li (22 shared papers)Dan Wu (4 shared papers)Na Wu (7 shared papers)Lei Tang (8 shared papers)Chunhua Wu (3 shared papers)Xiangyun Zhu (3 shared papers)C. Liu (2 shared papers)Hong Wei Ouyang (5 shared papers)
- Journals
- Diabetes Metabolic Syndrome and Obesity (10 papers)Diabetes Obesity and Metabolism (7 papers)PLoS ONE (6 papers)Frontiers in Endocrinology (6 papers)Medicine (4 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Ling Li
252 papers receiving 6.5k citations
Ling Li's Hit Papers
Peers
Comparison fields: 5 of 166
- Endocrinology, Diabetes and Metabolism 1.3k
- Obstetrics and Gynecology 537
- Geriatrics and Gerontology 142
- Cancer Research 429
- Physiology 612
Countries citing papers authored by Ling Li
This map shows the geographic impact of Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Li more than expected).
Fields of papers citing papers by Ling Li
This network shows the impact of papers produced by Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Li. The network helps show where Ling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Standards of medical care for type 2 diabetes in China 2019 Hit paper breakdown → | 2019 | 536 |
| 2 | 2016 | 283 | |
| 3 | 2017 | 171 | |
| 4 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Hit paper breakdown → | 2022 | 167 |
| 5 | 2011 | 157 | |
| 6 | 2017 | 151 | |
| 7 | 2007 | 130 | |
| 8 | 2014 | 126 | |
| 9 | 2020 | 121 | |
| 10 | 2015 | 121 | |
| 11 | 2006 | 119 | |
| 12 | 2013 | 115 | |
| 13 | 2014 | 115 | |
| 14 | 2021 | 113 | |
| 15 | 2015 | 104 | |
| 16 | 2018 | 104 | |
| 17 | 2017 | 84 | |
| 18 | 2012 | 84 | |
| 19 | 2011 | 80 | |
| 20 | 2017 | 74 |
About Ling Li
Ling Li is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism, Cancer Research, Molecular Biology and Epidemiology, having authored 263 papers that have together received 6.7k indexed citations. Recurring topics across this work include Gestational Diabetes Research and Management (27 papers), Diabetes Treatment and Management (19 papers), Thyroid Disorders and Treatments (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Pregnancy and preeclampsia studies (10 papers), Metabolism, Diabetes, and Cancer (9 papers), MicroRNA in disease regulation (7 papers) and Head and Neck Cancer Studies (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Obstetrics and Gynecology (537 citations), Geriatrics and Gerontology (142 citations), Cancer Research (429 citations) and Physiology (612 citations). Ling Li has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Ping Li, Dan Wu, Na Wu, Lei Tang, Chunhua Wu, Xiangyun Zhu, C. Liu, Hong Wei Ouyang, Lichao Zhang and Ding‐Feng Su. Their work appears in journals such as Diabetes Metabolic Syndrome and Obesity, Diabetes Obesity and Metabolism, PLoS ONE, Frontiers in Endocrinology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.